Fennec Pharmaceuticals (TSE:FRX) has released an update.
Fennec Pharmaceuticals Inc. has successfully elected its director nominees at the Annual General Meeting of Shareholders, with overwhelming support for each candidate and almost unanimous approval for the appointment of Haskell & White LLP as auditors. Shareholders showed strong endorsement for the executive compensation plan, with a high approval rating. The meeting signified shareholder confidence in the company’s leadership and direction.
For further insights into TSE:FRX stock, check out TipRanks’ Stock Analysis page.
